CHECKMATE PHARMACEUTICALS, INC. Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 20_____ Debt SecuritiesIndenture • September 7th, 2021 • Checkmate Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
THIS INDENTURE, dated as of [•], 20___, between CHECKMATE PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
OPEN MARKET SALE AGREEMENTSMOpen Market Sale Agreement • September 7th, 2021 • Checkmate Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
